查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813448

2032 年傳導神經監測市場預測：按產品類型、來源類型、應用、最終用戶和地區進行的全球分析

Conductive Neuromonitoring Market Forecasts to 2032 - Global Analysis By Product Type, Source Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球傳導神經監測市場預計在 2025 年達到 3.748 億美元，到 2032 年將達到 6.058 億美元，預測期內的複合年成長率為 7.1%。

傳導神經監測是利用電生理技術即時評估神經通路的完整性，該技術測量中樞和周圍神經系統的電傳導。它常用於外科手術過程中檢測潛在的神經病變，利用體感誘發電位 (SSEP)、運動誘發電位 (MEP) 和肌電圖 (EMG) 等技術。這種方法透過提供持續的功能狀態回饋，使臨床醫生能夠識別和預防術中神經損傷，從而提高患者安全性和手術效果。

神經系統疾病和慢性疾病的盛行率不斷上升

糖尿病和心血管疾病等慢性疾病常常導致需要手術干預的併發症，因此即時神經監測至關重要。傳導性神經監測技術正擴大被整合到外科手術工作流程中，以最大限度地減少術後殘疾並改善患者預後。此外，主要經濟體的人口老化也導致神經相關手術數量不斷增加，進一步推動了市場成長。神經診斷工具與先進監測系統的整合也推動了該領域的技術創新。

設備和程序高成本

傳導性神經監測系統的實施和維護成本高昂，需要複雜的硬體、專有軟體和熟練的人員。醫院和外科中心通常面臨預算限制，這限制了該技術的採用，尤其是在發展中地區。耗材、校準和定期升級的成本也加重了財務負擔。此外，保險報銷方面的挑戰以及神經監測服務缺乏全民覆蓋，也阻礙了小型醫療機構投資這些系統。

缺乏標準化的報銷政策

隨著神經監測成為複雜手術的護理標準，醫療保健提供者和行業相關人員呼籲更清晰的計費代碼和報銷流程。這一差距使公司能夠與監管機構和醫療機構合作，建立基於價值的定價模式。新興市場尤其成熟，可以建立結構化的報銷系統來激勵病患採用。此外，開發經濟高效的攜帶式神經監測設備有助於縮小可負擔性差距，擴大可近性。

外包監控服務需求不斷成長

第三方供應商提供成本更低的遠端監控解決方案，減少了對資本密集安裝的需求。外包雖然提高了擴充性和人員配置靈活性，但也帶來了與資料安全、服務可靠性和臨床課責相關的風險。嚴重依賴外部供應商的醫院可能面臨維持一致品質標準的挑戰。這種轉變可能會崩壞傳統的收益模式，並加劇服務供應商和設備製造商之間的競爭。

COVID-19的影響：

供應鏈中斷影響了關鍵部件的可得性，並延遲了安裝和維護計劃。然而，這場危機也凸顯了遠端監控和遠端神經病學的重要性，並刺激了無線和雲端整合神經監測平台的創新。疫情後復甦時期，手術量出現反彈，促使醫院優先考慮能夠提高術中安全性和減少併發症的技術，從而帶來了新的市場發展動能。

預計監控系統/單元部分在預測期內將佔最大佔有率

監測系統/裝置細分市場預計將在預測期內佔據最大市場佔有率，這得益於其在術中神經生理評估中的核心作用。這些系統提供神經功能的即時回饋，使外科醫生能夠在複雜的手術過程中做出明智的決策。如今，先進的設備融合了人工智慧主導的訊號解讀、多重模式整合和無線連接，從而提高了準確性和易用性。它們在神經外科、整形外科和心血管外科領域的廣泛應用，證明了其多功能性。

預計脊椎外科手術在預測期內的複合年成長率最高

預計脊椎外科手術領域將在預測期內達到最高成長率，這得益於脊椎畸形矯正、腫瘤切除和退化性椎間盤手術的興起。傳導性神經監測在這些手術過程中對保護運動和感覺路徑、降低癱瘓和神經損傷風險起著關鍵作用。電極設計、訊號保真度和即時分析方面的技術創新，使神經監測成為脊椎手術室的重要組成部分。外科醫生和患者對神經監測在脊椎護理中益處的認知不斷提高，也促進了神經監測領域的加速成長。

比最大的地區

預計北美將在預測期內佔據最大的市場佔有率，這得益於其強大的醫療基礎設施和較高的手術量。該地區受益於先進神經監測技術的早期採用以及主要設備製造商的強大影響力。優惠的報銷政策和完善的臨床指南進一步支持了其應用。美國和加拿大的學術機構和研究中心正在積極推動技術進步和臨床檢驗。

複合年成長率最高的地區：

由於醫療保健覆蓋範圍的擴大、外科手術數量的增加以及醫療技術投資的不斷增加，預計亞太地區將在預測期內實現最高的複合年成長率。中國、印度和韓國等國家正在快速實現外科基礎設施的現代化，為神經監測的應用創造了肥沃的土壤。政府旨在改善神經科護理和手術安全性的措施進一步推動了市場擴張。本土製造商正憑藉針對本地需求的經濟高效的解決方案進入該領域，加劇了競爭和創新。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 對最多三家其他市場公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球傳導神經監測市場（依產品類型）

  • 電極
    • 皮下針電極
    • 表面電極
    • 皮層電圖 (ECoG) 電極
  • 監測系統/單位
    • 腦電圖（EEG）設備
    • 肌電圖（EMG）設備
    • 誘發電位（EP）系統
      • 體感誘發電位（SSEP）
      • 運動誘發電位（MEP）
      • 腦幹聽覺誘發電位（BAEP）
      • 視覺誘發電位（VEP）
    • 多重模式系統
  • 配件及拋棄式用品
    • 電纜和導線
    • 導電凝膠和導電膏
    • 刺激器

6. 全球傳導神經監測市場（依來源類型）

  • 內部監控
  • 外包監控

7. 全球傳導神經監測市場（按應用）

  • 脊椎手術
    • 減壓手術
    • 脊椎融合手術
    • 脊椎矯正
  • 神經外科
    • 腦腫瘤切除術
    • 動脈瘤夾閉術
    • 功能神經外科（DBS）
  • 血管外科
  • 耳鼻喉手術
  • 其他用途

8. 全球傳導神經監測市場（依最終用戶）

  • 醫院
  • 門診手術中心（ASC）
  • 專科神經內科和神經外科中心
  • 其他最終用戶

9. 全球傳導神經監測市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Zimmer Biomet Holdings, Inc.
  • SpecialtyCare, Inc.
  • RHONEDERM GmbH
  • NuVasive, Inc.
  • Nihon Kohden Corporation
  • NeuroWave Systems Inc.
  • Neurosign Medical
  • Natus Medical Incorporated
  • Medtronic plc
  • Magstim Company Limited
  • LivaNova PLC
  • International Medical Systems Ltd.
  • Inomed Medizintechnik GmbH
  • GE HealthCare
  • Erbe Elektromedizin GmbH
  • Dr. Langer Medical GmbH
  • Computronics Healthcare
  • Cadwell Industries, Inc.
  • Bionen Co., Ltd.
  • AD-Tech Medical Instrument Corporation
Product Code: SMRC30897

According to Stratistics MRC, the Global Conductive Neuromonitoring Market is accounted for $374.8 million in 2025 and is expected to reach $605.8 million by 2032 growing at a CAGR of 7.1% during the forecast period. Conductive neuromonitoring is the real-time assessment of neural pathway integrity using electrophysiological techniques that measure electrical conduction across the central and peripheral nervous systems. Commonly employed during surgical procedures, it utilizes modalities such as somatosensory evoked potentials (SSEPs), motor evoked potentials (MEPs), and electromyography (EMG) to detect potential neural compromise. This approach enables clinicians to identify and prevent intraoperative neurological injury by providing continuous feedback on functional status, thereby enhancing patient safety and surgical outcomes.

Market Dynamics:

Driver:

Increasing prevalence of neurological and chronic disorders

Chronic disorders like diabetes and cardiovascular diseases often lead to complications requiring surgical interventions, where real-time nerve monitoring becomes critical. Conductive neuromonitoring technologies are increasingly integrated into surgical workflows to minimize postoperative deficits and enhance patient outcomes. Moreover, aging populations across major economies are contributing to a higher volume of neuro-related procedures, further accelerating market growth. The convergence of neurodiagnostic tools with advanced monitoring systems is also fostering innovation in this space.

Restraint:

High cost of equipment and procedures

Conductive neuromonitoring systems involve sophisticated hardware, proprietary software, and skilled personnel, making them expensive to deploy and maintain. Hospitals and surgical centers often face budget constraints, limiting the adoption of these technologies, especially in developing regions. The cost of consumables, calibration, and periodic upgrades adds to the financial burden. Additionally, reimbursement challenges and lack of universal coverage for neuromonitoring services discourage smaller facilities from investing in these systems.

Opportunity:

Lack of standardized reimbursement policies

As neuromonitoring becomes a standard of care in complex surgeries, healthcare providers and industry players are pushing for clearer billing codes and insurance coverage. This gap allows companies to collaborate with regulatory bodies and medical associations to establish value-based pricing models. Emerging markets, in particular, are ripe for structured reimbursement systems that can incentivize adoption. Furthermore, the development of cost-effective, portable neuromonitoring units may help bridge affordability gaps and expand access.

Threat:

Growing demand for outsourced monitoring services

Third-party providers offer remote monitoring solutions at lower costs, reducing the need for capital-intensive installations. While outsourcing improves scalability and staffing flexibility, it also introduces risks related to data security, service reliability, and clinical accountability. Hospitals relying heavily on external vendors may face challenges in maintaining consistent quality standards. This shift could potentially disrupt traditional revenue models and intensify competition among service providers and device manufacturers.

Covid-19 Impact:

Supply chain interruptions affected the availability of critical components, delaying installations and maintenance schedules. However, the crisis also underscored the importance of remote monitoring and tele-neurology, prompting innovation in wireless and cloud-integrated neuromonitoring platforms. Post-pandemic recovery has seen a rebound in surgical volumes, with hospitals prioritizing technologies that enhance intraoperative safety and reduce complications, thereby revitalizing market momentum.

The monitoring systems/units segment is expected to be the largest during the forecast period

The monitoring systems/units segment is expected to account for the largest market share during the forecast period due to its central role in intraoperative neurophysiological assessments. These systems offer real-time feedback on nerve function, enabling surgeons to make informed decisions during complex procedures. Advanced units now incorporate AI-driven signal interpretation, multi-modality integration, and wireless connectivity, enhancing precision and usability. Their widespread adoption across neurosurgery, orthopedic, and cardiovascular disciplines underscores their versatility.

The spinal surgery segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the spinal surgery segment is predicted to witness the highest growth rate driven by the increasing number of spinal deformity corrections, tumor resections, and degenerative disc interventions. Conductive neuromonitoring plays a vital role in preserving motor and sensory pathways during these procedures, reducing the risk of paralysis or nerve damage. Innovations in electrode design, signal fidelity, and real-time analytics are making neuromonitoring indispensable in spinal operating rooms. The rising awareness among surgeons and patients about the benefits of neuromonitoring in spinal care is also contributing to its accelerated growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share attributed to its robust healthcare infrastructure and high surgical volumes. The region benefits from early adoption of advanced neuromonitoring technologies and strong presence of leading device manufacturers. Favorable reimbursement policies and well-established clinical guidelines further encourage widespread use. Academic institutions and research centers in the U.S. and Canada are actively contributing to technological advancements and clinical validation.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR propelled by expanding healthcare access, rising surgical procedures, and increasing investments in medical technology. Countries like China, India, and South Korea are rapidly modernizing their surgical infrastructure, creating fertile ground for neuromonitoring adoption. Government initiatives aimed at improving neurological care and surgical safety are further driving market expansion. Local manufacturers are entering the space with cost-effective solutions tailored to regional needs, intensifying competition and innovation.

Key players in the market

Some of the key players in Conductive Neuromonitoring Market include Zimmer Biomet Holdings, Inc., SpecialtyCare, Inc., RHONEDERM GmbH, NuVasive, Inc., Nihon Kohden Corporation, NeuroWave Systems Inc., Neurosign Medical, Natus Medical Incorporated, Medtronic plc, Magstim Company Limited, LivaNova PLC, International Medical Systems Ltd., Inomed Medizintechnik GmbH, GE HealthCare, Erbe Elektromedizin GmbH, Dr. Langer Medical GmbH, Computronics Healthcare, Cadwell Industries, Inc., Bionen Co., Ltd., and AD-Tech Medical Instrument Corporation.

Key Developments:

In July 2025, Zimmer Biomet announced a definitive agreement to acquire Monogram Technologies to expand its robotics suite with semi- and fully-autonomous solutions (deal value reported ~$177M). The release frames the acquisition as adding autonomy to Zimmer's robotics roadmap and accelerating commercialization of semi/fully autonomous joint-replacement tech.

In June 2025, LivaNova announced it had initiated a CMS reconsideration process for national Medicare coverage of VNS Therapy and later issued Q2 2025 results / guidance updates. The announcements focus on reimbursement strategy for VNS and financial performance for 2025.

In May 2025, Natus Medical Incorporated announced the launch of BrainWatch(TM), a point-of-care EEG solution designed for critical-care settings. The release explains the product positioning (POC EEG for ICU/ED), key features and Natus's commercialization plans for 2025.

Product Types Covered:

  • Electrodes
  • Monitoring Systems/Units
  • Accessories & Disposables

Source Types Covered:

  • Insourced Monitoring
  • Outsourced Monitori

Applications Covered:

  • Spinal Surgery
  • Neurosurgery
  • Vascular Surgery
  • ENT Surgery
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Neurology & Neurosurgery Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Conductive Neuromonitoring Market, By Product Type

  • 5.1 Introduction
  • 5.2 Electrodes
    • 5.2.1 Subdermal Needle Electrodes
    • 5.2.2 Surface Electrodes
    • 5.2.3 Electrocorticography (ECoG) Electrodes
  • 5.3 Monitoring Systems/Units
    • 5.3.1 Electroencephalography (EEG) Machines
    • 5.3.2 Electromyography (EMG) Machines
    • 5.3.3 Evoked Potential (EP) Systems
      • 5.3.3.1 Somatosensory Evoked Potentials (SSEPs)
      • 5.3.3.2 Motor Evoked Potentials (MEPs)
      • 5.3.3.3 Brainstem Auditory Evoked Potentials (BAEPs)
      • 5.3.3.4 Visual Evoked Potentials (VEPs)
    • 5.3.4 Multimodality Systems
  • 5.4 Accessories & Disposables
    • 5.4.1 Cables & Leads
    • 5.4.2 Conductive Gels and Pastes
    • 5.4.3 Stimulators

6 Global Conductive Neuromonitoring Market, By Source Type

  • 6.1 Introduction
  • 6.2 Insourced Monitoring
  • 6.3 Outsourced Monitoring

7 Global Conductive Neuromonitoring Market, By Application

  • 7.1 Introduction
  • 7.2 Spinal Surgery
    • 7.2.1 Decompression Surgery
    • 7.2.2 Spinal Fusion
    • 7.2.3 Scoliosis Correction
  • 7.3 Neurosurgery
    • 7.3.1 Brain Tumor Resection
    • 7.3.2 Aneurysm Clipping
    • 7.3.3 Functional Neurosurgery (DBS)
  • 7.4 Vascular Surgery
  • 7.5 ENT Surgery
  • 7.6 Other Applications

8 Global Conductive Neuromonitoring Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Ambulatory Surgical Centers (ASCs)
  • 8.4 Specialty Neurology & Neurosurgery Centers
  • 8.5 Other End Users

9 Global Conductive Neuromonitoring Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Zimmer Biomet Holdings, Inc.
  • 11.2 SpecialtyCare, Inc.
  • 11.3 RHONEDERM GmbH
  • 11.4 NuVasive, Inc.
  • 11.5 Nihon Kohden Corporation
  • 11.6 NeuroWave Systems Inc.
  • 11.7 Neurosign Medical
  • 11.8 Natus Medical Incorporated
  • 11.9 Medtronic plc
  • 11.10 Magstim Company Limited
  • 11.11 LivaNova PLC
  • 11.12 International Medical Systems Ltd.
  • 11.13 Inomed Medizintechnik GmbH
  • 11.14 GE HealthCare
  • 11.15 Erbe Elektromedizin GmbH
  • 11.16 Dr. Langer Medical GmbH
  • 11.17 Computronics Healthcare
  • 11.18 Cadwell Industries, Inc.
  • 11.19 Bionen Co., Ltd.
  • 11.20 AD-Tech Medical Instrument Corporation

List of Tables

  • Table 1 Global Conductive Neuromonitoring Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Conductive Neuromonitoring Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Conductive Neuromonitoring Market Outlook, By Electrodes (2024-2032) ($MN)
  • Table 4 Global Conductive Neuromonitoring Market Outlook, By Subdermal Needle Electrodes (2024-2032) ($MN)
  • Table 5 Global Conductive Neuromonitoring Market Outlook, By Surface Electrodes (2024-2032) ($MN)
  • Table 6 Global Conductive Neuromonitoring Market Outlook, By Electrocorticography (ECoG) Electrodes (2024-2032) ($MN)
  • Table 7 Global Conductive Neuromonitoring Market Outlook, By Monitoring Systems/Units (2024-2032) ($MN)
  • Table 8 Global Conductive Neuromonitoring Market Outlook, By Electroencephalography (EEG) Machines (2024-2032) ($MN)
  • Table 9 Global Conductive Neuromonitoring Market Outlook, By Electromyography (EMG) Machines (2024-2032) ($MN)
  • Table 10 Global Conductive Neuromonitoring Market Outlook, By Evoked Potential (EP) Systems (2024-2032) ($MN)
  • Table 11 Global Conductive Neuromonitoring Market Outlook, By Somatosensory Evoked Potentials (SSEPs) (2024-2032) ($MN)
  • Table 12 Global Conductive Neuromonitoring Market Outlook, By Motor Evoked Potentials (MEPs) (2024-2032) ($MN)
  • Table 13 Global Conductive Neuromonitoring Market Outlook, By Brainstem Auditory Evoked Potentials (BAEPs) (2024-2032) ($MN)
  • Table 14 Global Conductive Neuromonitoring Market Outlook, By Visual Evoked Potentials (VEPs) (2024-2032) ($MN)
  • Table 15 Global Conductive Neuromonitoring Market Outlook, By Multimodality Systems (2024-2032) ($MN)
  • Table 16 Global Conductive Neuromonitoring Market Outlook, By Accessories & Disposables (2024-2032) ($MN)
  • Table 17 Global Conductive Neuromonitoring Market Outlook, By Cables & Leads (2024-2032) ($MN)
  • Table 18 Global Conductive Neuromonitoring Market Outlook, By Conductive Gels and Pastes (2024-2032) ($MN)
  • Table 19 Global Conductive Neuromonitoring Market Outlook, By Stimulators (2024-2032) ($MN)
  • Table 20 Global Conductive Neuromonitoring Market Outlook, By Source Type (2024-2032) ($MN)
  • Table 21 Global Conductive Neuromonitoring Market Outlook, By Insourced Monitoring (2024-2032) ($MN)
  • Table 22 Global Conductive Neuromonitoring Market Outlook, By Outsourced Monitoring (2024-2032) ($MN)
  • Table 23 Global Conductive Neuromonitoring Market Outlook, By Application (2024-2032) ($MN)
  • Table 24 Global Conductive Neuromonitoring Market Outlook, By Spinal Surgery (2024-2032) ($MN)
  • Table 25 Global Conductive Neuromonitoring Market Outlook, By Decompression Surgery (2024-2032) ($MN)
  • Table 26 Global Conductive Neuromonitoring Market Outlook, By Spinal Fusion (2024-2032) ($MN)
  • Table 27 Global Conductive Neuromonitoring Market Outlook, By Scoliosis Correction (2024-2032) ($MN)
  • Table 28 Global Conductive Neuromonitoring Market Outlook, By Neurosurgery (2024-2032) ($MN)
  • Table 29 Global Conductive Neuromonitoring Market Outlook, By Brain Tumor Resection (2024-2032) ($MN)
  • Table 30 Global Conductive Neuromonitoring Market Outlook, By Aneurysm Clipping (2024-2032) ($MN)
  • Table 31 Global Conductive Neuromonitoring Market Outlook, By Functional Neurosurgery (DBS) (2024-2032) ($MN)
  • Table 32 Global Conductive Neuromonitoring Market Outlook, By Vascular Surgery (2024-2032) ($MN)
  • Table 33 Global Conductive Neuromonitoring Market Outlook, By ENT Surgery (2024-2032) ($MN)
  • Table 34 Global Conductive Neuromonitoring Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 35 Global Conductive Neuromonitoring Market Outlook, By End User (2024-2032) ($MN)
  • Table 36 Global Conductive Neuromonitoring Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 37 Global Conductive Neuromonitoring Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 38 Global Conductive Neuromonitoring Market Outlook, By Specialty Neurology & Neurosurgery Centers (2024-2032) ($MN)
  • Table 39 Global Conductive Neuromonitoring Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.